From: http://effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?productid=1144&pageaction=displayproduct
This summary covers what research says about the possible benefits and side effects of treatments to help prevent a blood clot after hip or knee surgery. Treatment options include medicines that thin your blood and devices that increase blood flow in your legs (leg or foot coverings that inflate and deflate or elastic stockings). This summary can help you discuss these options with your doctor.
The information comes from a report that reviewed 179 studies published between January 1980 and May 2011. The report was funded by the Agency for Healthcare Research and Quality (AHRQ), a Federal Government research agency. For a copy of the full report, go to www.effectivehealthcare.ahrq.gov/thrombo.cfm.
When a blood vessel is injured, the cells of your blood bond together to form a blood clot. The blood clot helps you stop bleeding. Blood clots are made of a combination of blood cells, platelets (small sticky cells that speed up the clot-making process), and fibrin (protein that forms a thread-like mesh to trap cells). Doctors call this kind of blood clot a “thrombus.”
Blood clots are good when they help seal a cut to stop bleeding. But sometimes, a blood clot can form when it is not needed. This type of blood clot can cause health problems or even death.
What blood clots are most dangerous?
What is the risk of getting a blood clot after hip or knee surgery?
DVT is the most common kind of blood clot people have after surgery for a total hip replacement, total knee replacement, or a broken hip. Most people who have one of these major surgeries are less active for several days or weeks after the surgery. This can cause blood flow to slow down, which increases the risk for a blood clot. People with a DVT may not have any symptoms and may not know they have one.
As many as 4 people out of 10 who do not receive medicine to prevent blood clots develop a DVT within 1 or 2 weeks of having major hip or knee surgery.
Taking medicine or using a device to prevent blood clots may lower the risk of developing a DVT after hip or knee surgery to 1 or 2 people out of 10.
Research found that people with congestive heart failure (a condition in which the heart is not able to pump enough blood through the body) were at a greater risk for having a blood clot after major hip or knee surgery.
Why prevent blood clots after hip or knee surgery?
Although DVTs and PEs can be treated, and many go away without treatment, your doctor or surgeon may suggest devices or medicine to help prevent these blood clots. These treatments are usually given soon after surgery.
Medical Devices To Prevent DVTs and PEs
Device |
Description and Information |
---|---|
Compression stockings |
Stockings made of strong elastic gently squeeze your calf and leg to increase blood flow. Stockings come in full-leg or calf lengths. Full-leg stockings may be difficult and uncomfortable to put on and take off. |
Intermittent pneumatic (new-MAT-ik) compression devices |
Leg coverings inflate and deflate with an air pump to squeeze your legs throughout the day and night. |
Venous foot pumps |
Foot covers inflate and deflate with an air pump to increase the blood flow in your legs. |
Medicines To Prevent DVTs and PEs
Type of Medicine |
Generic Name (Brand Name) |
How It Is Taken |
---|---|---|
Oral antiplatelet agents |
Aspirin |
Pill or liquid |
Low-molecular-weight heparin (LMWH) |
|
Shot |
Unfractionated heparin (UFH) |
Heparin sodium |
Shot |
Factor Xa inhibitors |
Fondaparinux (Arixtra®) |
Shot |
Rivaroxaban (Xarelto®) |
Pill |
|
Vitamin K antagonists |
Warfarin (Coumadin®, Jantoven®) |
Pill |
Benefits
Side Effects
How the Benefits and Side Effects of Medical Devices and Medicines Compare
|
Benefits |
Side Effects |
---|---|---|
* Most studies were done with people who had hip replacement surgery or surgery for a broken hip. DVT = deep vein thrombus; LMWH = low-molecular-weight heparin; PE = pulmonary embolism; UFH = unfractionated heparin |
||
All medicines to prevent blood clots |
People who take medicines to prevent blood clots have a lower chance of having a DVT than those who do not take medicine. |
People who take medicines to prevent blood clots have a higher chance of bleeding than those who do not take medicine. |
Comparing specific medicines |
LMWH lowers the chance of having blood clots more than UFH does. |
People who take LMWH have a lower chance of bleeding than those who take UFH. |
LMWH lowers the chance of having certain types of blood clots more than warfarin (Coumadin®) does. |
People who take warfarin (Coumadin®) have a lower chance of bleeding than those who take LMWH. |
|
Fondaparinux (Arixtra®) lowers the chance of having certain types of blood clots more than LMWH does. |
|
|
Comparing medicines and medical devices |
People taking medicines to prevent blood clots have a lower chance of getting a DVT than people using medical devices. |
People taking medicines to prevent blood clots have a higher chance of bleeding than people using medical devices. |
Comparing specific medical devices |
There is not enough research to know if any one of these devices reduces the chance of a blood clot any more than the others. |
There is not enough research to know if there are any side effects from using any of these medical devices. |
Taking medicine for 28 days or longer |
Taking medicine for 28 days or longer reduces the chance of having a DVT or PE more than taking medicine for 7 to 10 days.* |
There is a higher chance of bleeding when the medicine is taken for 28 days or longer than when it is taken for 7 to 10 days.* |
You and your doctor will need to discuss which medicines or devices might be best to prevent blood clots after hip or knee replacement surgery or surgery for a broken hip. Medicines can help prevent blood clots, but they can also slightly increase your risk for bleeding. For most people, the risk of getting a blood clot after surgery is higher than the risk of bleeding while taking the medicine. The treatment your doctor suggests may depend on several factors, including:
The cost to you for each medicine depends on your health insurance, the dose (amount) needed, and whether the medicine comes in a generic form.
Wholesale Prices of Medicines That Prevent Blood Clots
Brand Name |
Form Given |
Typical Dose* |
Price Per Day of Brand Name |
Generic Name |
Price Per Day of Generic Form |
---|---|---|---|---|---|
* Typical dose is an average. Your doctor may prescribe a different dose and may change the amount you take several times. Prices are the average wholesale prices from RED BOOK Online®. |
|||||
LMWH |
|||||
Fragmin® |
Shot† |
5,000 units once a day |
$39 |
Dalteparin |
N/A |
Innohep® |
Shot† |
20,000 units once a day |
N/A |
Tinzaparin |
N/A |
Lovenox® |
Shot† |
30 mg/ml twice a day 40 mg/ml once a day |
$60 $40 |
Enoxaparin |
$48 $32 |
UFH |
|||||
This product has multiple names. |
Shot† |
5,000 units three times a day |
N/A |
Heparin |
$16 |
Factor Xa Inhibitors |
|||||
Arixtra® |
Shot† |
2.5 mg once a day |
$64 |
Fondaparinux |
$11 |
Xarelto® |
Pill |
10 mg once a day |
$9 |
Rivaroxaban |
N/A |
Vitamin K Antagonists |
|||||
Coumadin®; Jantoven® |
Pill |
2 mg once a day 5 mg once a day 10 mg once a day |
$2; $1 for all doses |
Warfarin |
$1 for all doses of both brand names |
The information in this summary comes from the report Venous Thromboembolism Prophylaxis in Orthopedic Surgery, March 2012.
The report was produced by the University of Connecticut/Hartford Hospital Evidence-based Practice Center through funding by the Agency for Healthcare Research and Quality (AHRQ).
For a copy of the report or for more information about AHRQ and the Effective Health Care Program, go to www.effectivehealthcare.ahrq.gov/thrombo.cfm. Additional information came from the MedlinePlus® Web site, a service of the National Library of Medicine and the National Institutes of Health. This site is available at www.nlm.nih.gov/medlineplus.
This summary was prepared by the John M. Eisenberg Center for Clinical Decisions and Communications Science at Baylor College of Medicine, Houston, TX. It was written by Andrea Humphries, Ph. D, Amelia Williamson Smith, M.S., Kim Farina, Ph.D., Thomas Workman, Ph.D., Melvyn Harrington, Jr., M.D., and Michael Fordis, M.D. Illustrations were created by Douglas Alexander. People with hip and knee replacements reviewed this summary.